Boryung

Boryung EBIT Margin

The EBIT Margin (Operating Margin) of Boryung (003850.KS) as of Oct 30, 2026 is 7.16 %. In the previous year, EBIT Margin (Operating Margin) was 6.93 % — a change of 3.36% (higher).

EBIT Margin

7.16 %

YoY

3.36%

Last updated:

EBIT Margin (Operating Margin) of Boryung is 2025 7.16 % . EBIT Margin (Operating Margin) of Boryung was 2024 6.93 % . It decreases by 3.36% higher compared to the previous year.

For Boryung, the operating (EBIT) margin of 7.2% is down versus 11.8% a few years ago.

The Boryung EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2018
5.42 KRW
Jan 1, 2019
7.46 KRW
Jan 1, 2020
7.12 KRW
Jan 1, 2021
11.76 KRW
Jan 1, 2022
7.95 KRW
Jan 1, 2023
7.94 KRW
Jan 1, 2024
6.93 KRW
Jan 1, 2025
7.16 KRW
The Boryung EBIT Margin history
YEAREBIT MarginYoY
7.16 %+3.36%
6.93 %-12.75%
7.94 %-0.14%
7.95 %-32.41%
11.76 %+65.31%
7.12 %-4.60%
7.46 %+37.63%
5.42 %+2,146.20%
0.24 %-95.52%
5.38 %-21.62%
6.86 %+1.00%
6.80 %+11,524.35%
0.06 %+441.22%
0.01 %-48.92%
0.02 %-65.62%
0.06 %+61.90%
0.04 %-5.63%
0.04 %-42.06%
0.07 %+387.51%
0.01 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Boryung Stock analysis

What does Boryung do? Boryung Corp is a South Korean company that was founded in 1963 and is headquartered in Seoul. The founders are In-Bum Kim and Myung-Chul Kang. The company is very successful in the pharmaceutical and cosmetic industries. It has a leading position in the prescription drug market and has also specialized in the development and marketing of over-the-counter products. History: Boryung Corp has experienced impressive growth in various areas over the past decades. The company's original focus was the production of pharmaceutical products for the local healthcare industry. Thanks to hard work and large investments, Boryung began to succeed in international markets for pharmaceutical products. The company expanded its business operations by establishing a branch for cosmetic products as well as food and beverage production. Business model: Boryung Corp's business model is based on marketing medical products for domestic and international markets, as well as developing and marketing cosmetics and dietary supplements. The company sells its products under various brands, including Valtocin (for high blood pressure), Eumosone (for skin conditions), and Rapithon (for colds). The company aims to make its brands synonymous with quality and effectiveness in the markets where it operates. Various divisions: Boryung Corp has various divisions and subsidiaries specializing in different categories of products. The company operates a branch for cosmetic products (known as K-beauty). Notable cosmetic brands of Boryung include Mizon (skin care products), AHC (high-quality cosmetics), and Ryo (hair care series). The company also produces high-quality food and beverages, including soy products, instant noodles, and energy drinks. Products: Boryung offers a wide range of products, including prescription drugs, over-the-counter medications, consumer goods, and cosmetics. The company's prescription drugs are in high demand and include a wide range of products such as antibiotics, antidiabetic drugs, antihypertensives, as well as medications for skin diseases, cancer, and diabetes. Boryung is also very active in product-related research and development, investing a significant portion of its revenue in research and development. Conclusion: Boryung Corp has repeatedly proven over the years that it is an extremely versatile and successful company operating in a variety of business sectors. The company has established a strong position in the prescription drug and cosmetic product markets and is also involved in other business areas. Through continuous research and development of new products and the expansion of existing product lines, the company is driving its growth forward. Boryung is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Boryung stock

EBIT Margin (Operating Margin) of Boryung is 7.16 % in 2025.

EBIT Margin (Operating Margin) of Boryung changed from 6.93 % to 7.16 %, representing a 3.36% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Boryung since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Boryung with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Boryung

All Key Metrics — Boryung